Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Skint-like protein 1 (**SKINT1L**), also known as "Skint1 like" or "BTN12," is named for its sequence similarity to Skint1, a member of the immunoglobulin superfamily expressed primarily in epithelial tissues rich in T cells[1]. SKINT1L is closely related to **butyrophilin-like proteins** such as Btnl1, which regulate immune responses in epithelial tissues, specifically affecting subsets of intraepithelial lymphocytes (IELs) and influencing their repertoire and responses[1]. In mice, closely related molecules like Skint1 and Btnl1 are vital for the development and regulation of unconventional T cell populations in epithelial compartments, but a direct therapeutic targeting of SKINT1L has not been established, and its function in human disease remains largely uncharacterized[1]. **Critical clarification and limitations:** - The abbreviation **SKINT1L** customarily refers to *Skint-like protein 1*, but most functional data and nomenclature are derived from mouse genes/proteins (such as Skint1 and Btnl1)[1]. - In humans, the Skint1-like gene (SKINT1L/BTN12) is present but appears to be a **pseudogene** or of uncertain function, unlike the mouse homologue Skint1, which is functional and central to dendritic epidermal T cell development. No established data supports SKINT1L as a therapeutic target, receptor, or clinically actionable protein in humans[1]. - The alternative name **BTN12** reflects its close relationship to butyrophilin and butyrophilin-like gene families, but also introduces confusion with the established butyrophilin nomenclature[1]. **Summary of errors/uncertainties:** - **SKINT1L is not an established therapeutic target, receptor, or druggable protein in human medicine, and its biological and pathological roles in humans are not well-defined.** Its closest characterized functions relate to murine epithelial immunity, and much of the available literature covers analogs like Skint1 and Btnl1, not human SKINT1L[1]. - If your intent is to find a druggable human receptor or well-defined molecular target, **SKINT1L/BTN12 is not appropriate; consider related, functional butyrophilin(-like) proteins instead.**
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skint-like protein 1 (SKINT1L).